Event-Driven Stocks

BIODESIX INC

BDSXNasdaq

Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$88.5M$71.3M$49.1M$38.2M$54.5M$45.6M
Operating income−$27.9M−$34.5M−$41.3M−$50.6M−$40.9M−$22.9M
Net income−$35.3M−$42.9M−$52.1M−$65.4M−$43.2M−$31.4M
Total assets$87.5M$97.2M$99.1M$92.9M$76.1M$121.1M
Total liabilities$89.9M$76.4M$94.5M$72.3M$56.4M$79.9M
Equity−$2.5M$20.9M$4.6M$20.6M$19.7M$41.2M
EPS (diluted)$-4.67$-6.64$-0.64$-1.55$-1.58—
Shares out.146.0M96.9M78.0M31.3M26.6M26.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−31.5%
Net margin
−39.8%
Return on equity
1430.6%
Return on assets
−40.3%
Return on capital (ROCE)
−39.8%
Liabilities / assets
102.8%
Debt / equity
—
Book value / share
$-0.02
Revenue growth (YoY)
24.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-19.59distress
Accruals / assets
−13.7%clean
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
56
/ 100
Profitability 20Growth 100Catalyst 67Earnings quality 67Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 2 severe● 4 warning● 3 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026137,1961.4-7.3%
Apr 30, 2026148,0122.5-14.9%
Apr 15, 2026174,0163.1-4.3%
Mar 31, 2026181,8182.4+1.5%
Mar 13, 2026179,0991.0-19.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.